A pilot study of treatment of lentigo maligna with 5% imiquimod cream

C. J. Fleming, A. M. Bryden, A. Evans, R. S. Dawe, S. H. Ibbotson

    Research output: Contribution to journalArticle

    86 Citations (Scopus)

    Abstract

    Lentigo maligna (LM) is an in situ form of malignant melanoma, and surgical excision is often unsatisfactory. Imiquimod cream is an immune response modifier and induces a predominantly T-helper 1 type response.
    Original languageEnglish
    Pages (from-to)485-488
    Number of pages4
    JournalThe British journal of dermatology
    Volume151
    Issue number2
    DOIs
    Publication statusPublished - Aug 2004

    Keywords

    • Aminoquinolines
    • Hutchinson's Melanotic Freckle
    • Antineoplastic Agents
    • Humans
    • Adult
    • Treatment Outcome
    • Aged
    • Pilot Projects
    • Middle Aged
    • Skin Neoplasms
    • Administration, Topical

    Fingerprint Dive into the research topics of 'A pilot study of treatment of lentigo maligna with 5% imiquimod cream'. Together they form a unique fingerprint.

    Cite this